|
Volumn 24, Issue 1, 2010, Pages 2-
|
Combined therapy: The future has already come
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
ANTILIPEMIC AGENT;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
CARDIOVASCULAR DISEASE;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG MECHANISM;
DYSLIPIDEMIA;
EDITORIAL;
HUMAN;
HYPERTENSION;
PILL;
POLYPHARMACY;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
RISK FACTOR;
TABLET FORMULATION;
ANTIHYPERTENSIVE AGENTS;
CARDIOVASCULAR DISEASES;
DRUG COMBINATIONS;
HUMANS;
HYPERTENSION;
RISK FACTORS;
|
EID: 74049128835
PISSN: 07673981
EISSN: 14728206
Source Type: Journal
DOI: 10.1111/j.1472-8206.2009.00808_2.x Document Type: Editorial |
Times cited : (2)
|
References (0)
|